Literature DB >> 25378054

Gremlin1 preferentially binds to bone morphogenetic protein-2 (BMP-2) and BMP-4 over BMP-7.

Rachel H Church1, Arjun Krishnakumar1, Annika Urbanek2, Stefan Geschwindner3, Julie Meneely4, Alessandro Bianchi2, Barbro Basta3, Sean Monaghan1, Christopher Elliot4, Maria Strömstedt3, Neil Ferguson2, Finian Martin2, Derek P Brazil1.   

Abstract

Gremlin (Grem1) is a member of the DAN family of secreted bone morphogenetic protein (BMP) antagonists. Bone morphogenetic protein-7 (BMP-7) mediates protective effects during renal fibrosis associated with diabetes and other renal diseases. The pathogenic mechanism of Grem1 during diabetic nephropathy (DN) has been suggested to be binding and inhibition of BMP-7. However, the precise interactions between Grem1, BMP-7 and other BMPs have not been accurately defined. In the present study, we show the affinity of Grem1 for BMP-7 is lower than that of BMP-2 and BMP-4, using a combination of surface plasmon resonance and cell culture techniques. Using kidney proximal tubule cells and HEK (human embryonic kidney)-293 cell Smad1/5/8 phosphorylation and BMP-dependent gene expression as readouts, Grem1 consistently demonstrated a higher affinity for BMP-2>BMP-4>BMP-7. Cell-associated Grem1 did not inhibit BMP-2- or BMP-4-mediated signalling, suggesting that Grem1-BMP-2 binding occurred in solution, preventing BMP receptor activation. These data suggest that Grem1 preferentially binds to BMP-2 and this may be the dominant complex in a disease situation where levels of Grem1 and BMPs are elevated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25378054     DOI: 10.1042/BJ20140771

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  EXPRESS: Gremlin1 blocks vascular endothelial growth factor signalling in the pulmonary microvascular endothelium.

Authors:  Simon Coyle Rowan; Lucie Piouceau; Joanna Cornwell; Lili Li; Paul McLoughlin
Journal:  Pulm Circ       Date:  2018-10-04       Impact factor: 3.017

Review 2.  Agonists and Antagonists of TGF-β Family Ligands.

Authors:  Chenbei Chang
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-08-01       Impact factor: 10.005

3.  Overexpression of Gremlin promotes non-small cell lung cancer progression.

Authors:  Yunhong Yin; Yie Yang; Liyun Yang; Yan Yang; Chunyu Li; Xiao Liu; Yiqing Qu
Journal:  Tumour Biol       Date:  2015-09-21

Review 4.  The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.

Authors:  Daniel Karin; Yukinori Koyama; David Brenner; Tatiana Kisseleva
Journal:  Differentiation       Date:  2016-08-31       Impact factor: 3.880

5.  LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway.

Authors:  Chao Fu; Dongyuan Li; Xiaonan Zhang; Naijie Liu; Guonan Chi; Xingyi Jin
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 6.  TGF-β Family Signaling in Early Vertebrate Development.

Authors:  Joseph Zinski; Benjamin Tajer; Mary C Mullins
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

Review 7.  Gremlin: a complex molecule regulating wound healing and fibrosis.

Authors:  Steven O'Reilly
Journal:  Cell Mol Life Sci       Date:  2021-11-03       Impact factor: 9.261

8.  Control of ovarian follicle development by TGFβ family signaling.

Authors:  Bethany K Patton; Surabhi Madadi; Stephanie A Pangas
Journal:  Curr Opin Endocr Metab Res       Date:  2021-03-11

9.  Structure of Gremlin-1 and analysis of its interaction with BMP-2.

Authors:  Miglė Kišonaitė; Xuelu Wang; Marko Hyvönen
Journal:  Biochem J       Date:  2016-04-01       Impact factor: 3.857

10.  Bone Morphogenetic Protein Antagonist Gremlin-1 Increases Myofibroblast Transition in Dermal Fibroblasts: Implications for Systemic Sclerosis.

Authors:  Laura Duffy; John Henderson; Max Brown; Stefan Pryzborski; Nicola Fullard; Lena Summa; Jorg H W Distler; Richard Stratton; Steven O'Reilly
Journal:  Front Cell Dev Biol       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.